Suchergebnisse - (Subject:"Pneumonia")

PubPharm (2.700)

1

Changing clinical characteristics of pediatric inpatients with pneumonia during COVID-19 pandamic : a retrospective study

enthalten in: Italian journal of pediatrics | 2024

von Chen, M. | Zhou, Y. | Jin, S. | +11

2

Changing clinical characteristics of pediatric inpatients with pneumonia during COVID-19 pandamic: a retrospective study

enthalten in: The Italian journal of pediatrics | 2024

von Chen, M. | Zhou, Y. | Jin, S. | +11

3

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) : Biomarker-Guided Early Elarithromycin Treatment to Prevent Sepsis Progression in Community-Acquired Pneumonia: The React Randomized Clinical Trial

enthalten in: ClinicalTrials.gov | 2024

4

Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

enthalten in: Intensive care medicine experimental | 2024

von Mattei, A. | Schiavoni, L. | Riva, E. | +10

5

Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

enthalten in: Intensive Care Medicine Experimental | 2024

von Mattei, A. | Schiavoni, L. | Riva, E. | +10

6

The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection

enthalten in: Biochimica et biophysica acta. Molecular basis of disease | 2024

von Fernández, J. | Marín, A. | Rosales, R. | +28

7

Clinical characteristics of COVID-19 infection in patients undergoing hemodialysis

enthalten in: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences | 2024

von Zhu, J. | Zhao, Y. | Huang, W. | +4

8

Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era : a single center, observational study

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2024

von Oliva, A. | Liguori, L. | Covino, S. | +13

9

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity : Light Therapy in Patients Undergoing an Operation for Appendicitis, a Septic Joint, Necrotizing Soft Tissue Infection, Diverticulitis, or Medical Treatment of Pneumonia

enthalten in: ClinicalTrials.gov | 2024

10

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia : Reparixin 1200 mg TID as add-on to SoC to Limit Disease Progression in Hospitalised Patients With COVID-19 and Other Community-Acquired Pneumonia. A Multicentre, Randomised, Double-blinded, Placebo-controlled, Phase III Trial (REPAVID-22)

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[270]